ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,775 | -10.9% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $14,340 | +19.6% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $11,985 | +41.3% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $8,480 | +21.1% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -12.5% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -38.5% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | -31.6% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | -20.8% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | +41.2% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $17,000 | -19.0% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $21,000 | -4.5% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | +4.8% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -8.7% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $23,000 | +666.7% | 500 | +150.0% | 0.00% | – |
| Q1 2020 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |